Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page
- Check5 days agoChange DetectedThe page's revision indicator was updated from v3.6.2 to v3.6.3, signaling a small maintenance update to the site.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.6.2 was added and Revision: v3.6.0 was removed, indicating a software update to the page. This change does not affect the study details, eligibility criteria, or any content about the clinical trial.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRecruitment status is updated to indicate enrollment is closed, and new user-guidance sections were added to help users understand the study record and how to join. A label formatting change for Intervention/Treatment and a revision tag update were also applied.SummaryDifference0.5%

- Check33 days agoChange DetectedThe page revision in the footer was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This reflects a metadata update rather than a change to the visible content.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the Related Topics entries (including Prostate cancer and MedlinePlus Genetics) from the study page. This reduces the related resources displayed alongside the study details, affecting navigational context for users exploring related topics.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page's related topics area gained Prostate cancer and a MedlinePlus Genetics link, and the site revision updated from v3.5.3 to v3.5.4.SummaryDifference0.2%

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.